Research graph
References from Sex-based survival disparities in patients with stage I–III non-small cell lung cancer vary by treatment modality. Local targets link to admitted publications; unresolved targets remain external evidence.
Sex disparities in advanced non-small cell lung cancer survival: a Danish nationwide study
10.1016/j.lungcan.2025.108485 · 2025 · External reference
Sex differences in lung cancer treatment and outcomes at a large hybrid academic-community practice
10.1016/j.jtocrr.2022.100307 · 2022 · External reference
Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese lung cancer registry study
10.1097/jto.0b013e3181f1923b · 2010 · External reference
Evaluating prognostic factors for sex differences in lung cancer survival: findings from a large Australian cohort
10.1016/j.jtho.2022.01.016 · 2022 · External reference
Sex and survival after surgery for lung cancer: a Swedish nationwide cohort
10.1016/j.chest.2020.11.010 · 2021 · External reference
Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients
10.21037/tlcr-24-336 · 2024 · External reference
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdx222 · 2017 · External reference
Lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology
10.6004/jnccn.2204.0023 · 2024 · External reference
Trends and variations in treatment of stage I-III non-small cell lung cancer from 2008 to 2018: a nationwide population-based study from the Netherlands
10.1016/j.lungcan.2021.03.013 · 2021 · External reference
Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer
10.1002/cncr.24361 · 2009 · External reference
Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy
10.1093/jjco/hyp095 · 2009 · External reference
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion
10.1158/1078-0432.ccr-21-0136 · 2021 · External reference
Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
10.3389/fimmu.2022.1074477 · 2022 · External reference
Tumor-intrinsic determinants of immunogenic cell death modalities
10.1080/2162402x.2021.1893466 · 2021 · External reference
Sex differences in the response to lung cancer and its relation to programmed cell death protein-1/programmed death-ligand-1 checkpoint therapies
10.3390/cancers17243953 · 2025 · External reference
Estrogens, cancer and immunity
10.3390/cancers14092265 · 2022 · External reference
Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review
10.1007/s00432-020-03197-8 · 2020 · External reference
Updated prognostic factors in localized NSCLC
10.3390/cancers14061400 · 2022 · External reference
Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer
10.1002/cncr.24361 · ExternalCitation · doi-reference
Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review
10.1007/s00432-020-03197-8 · ExternalCitation · doi-reference
Sex and survival after surgery for lung cancer: a Swedish nationwide cohort
10.1016/j.chest.2020.11.010 · ExternalCitation · doi-reference
Evaluating prognostic factors for sex differences in lung cancer survival: findings from a large Australian cohort
10.1016/j.jtho.2022.01.016 · ExternalCitation · doi-reference
Sex differences in lung cancer treatment and outcomes at a large hybrid academic-community practice
10.1016/j.jtocrr.2022.100307 · ExternalCitation · doi-reference
Trends and variations in treatment of stage I-III non-small cell lung cancer from 2008 to 2018: a nationwide population-based study from the Netherlands
10.1016/j.lungcan.2021.03.013 · ExternalCitation · doi-reference
Sex disparities in advanced non-small cell lung cancer survival: a Danish nationwide study
10.1016/j.lungcan.2025.108485 · ExternalCitation · doi-reference
Tumor-intrinsic determinants of immunogenic cell death modalities
10.1080/2162402x.2021.1893466 · ExternalCitation · doi-reference
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdx222 · ExternalCitation · doi-reference
Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy
10.1093/jjco/hyp095 · ExternalCitation · doi-reference
Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese lung cancer registry study
10.1097/jto.0b013e3181f1923b · ExternalCitation · doi-reference
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion
10.1158/1078-0432.ccr-21-0136 · ExternalCitation · doi-reference
Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients
10.21037/tlcr-24-336 · ExternalCitation · doi-reference
Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
10.3389/fimmu.2022.1074477 · ExternalCitation · doi-reference
Updated prognostic factors in localized NSCLC
10.3390/cancers14061400 · ExternalCitation · doi-reference
Estrogens, cancer and immunity
10.3390/cancers14092265 · ExternalCitation · doi-reference
Sex differences in the response to lung cancer and its relation to programmed cell death protein-1/programmed death-ligand-1 checkpoint therapies
10.3390/cancers17243953 · ExternalCitation · doi-reference
Lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology
10.6004/jnccn.2204.0023 · ExternalCitation · doi-reference
